Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2025-12-24 @ 2:08 PM
NCT ID:
NCT01577095
Eligibility Criteria:
Inclusion Criteria:
* all included native Taiwanese patients, age from 20 to 65 years who diagnosed with type 2 diabetes mellitus within 5 years and keep the same anti-hyperglycemic agents for control diabetes before and during the period in this study
* compatible with the diagnostic criteria of diabetes mellitus according to American Diabetes Association
Exclusion Criteria:
* individuals with nephrotic syndrome (urine protein over 3.5 g/day) and edema or renal failure (serum creatinine over 115 μmol/L)
* individuals who were diagnosed of heart failure (NYHA Fc III\~IV) or pacemaker implantation
* individuals with abnormal liver function (GOT and GPT level above 2 folds of normal range) or diagnosis of liver cirrhosis
* individuals with higher HbA1C level (HbA1C above 9%)
* pregnant women
* individuals who were receiving the classes of drugs thiazolidinediones already
* individuals who were receiving insulin therapy already
* individuals who were receiving other therapy during the period of study
* individuals suffering a homeostasis disorder or other systemic disease
* individuals who did not comply with the treatment during the study period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT01577095
Study Brief:
Protocol Section:
NCT01577095